Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Dear SRNE Stock Fans, Here’s the Latest Patent News to Watch

Despite some relatively bullish news that came out yesterday, investors in vaccine stocks such as SRNE stock are in sell mode today.

Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today

Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector.

BNGO Stock: What Is Driving Bionano Genomics Higher Today?

Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping.

Dear ARBK Stock Fans, Here’s the Latest Crypto-Mining News to Watch

Today, Argo Blockchain announced plans to ramp up its crypto-mining capacity, a move that's had little effect on ARBK stock.

Casper Price Predictions: How High Can the CSPR Crypto Go?

Here's where the experts line up in terms of Casper price predictions, as investors consider what the upside is for the CSPR crypto.